跳至主要内容
临床试验/NL-OMON21230
NL-OMON21230尚未招募不适用

Taste and smell disturbances in patients with gastrointestinal stromal tumors using tyrosine-kinase inhibitors.

niversity Medical Center Groningen0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Pathologically confirmed diagnosis of a GIST
  • -Currently treated with imatinib, sunitinib or regorafenib
  • -Able to understand spoken and written Dutch
  • -Ability to comprehend and complete questionnaire by phone
  • -> 18 years

排除标准

  • -No oral food intake
  • -Coexisting-morbidities affecting taste or smell function
  • -Uncertainty about the willingness or ability of the patient to comply with the protocol requirements

研究者

相似试验